Compare Medpace Holdings Inc (MEDP) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Medpace Holdings Inc trades at $615.82 (market cap $16.82B), while iShares 20 Plus Year Treasury Bond ETF trades at $77.88 (market cap $47.61B). The key difference: iShares 20 Plus Year Treasury Bond ETF is far larger — about 2.8× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, iShares 20 Plus Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and iShares 20 Plus Year Treasury Bond ETF for 83 Days on average.
| MEDP | TLT | |
|---|---|---|
Market Cap | $16.82B | $47.61B |
Volume | 223,093 | 49,263,490 |
Sector | Health | Fixed Income |
52-Week High | $630.19 | $92.06 |
52-Week Low | $393.42 | $77.11 |
Typical Hold Time | 14 Days | 83 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
TLT, the iShares 20+ Year Treasury Bond ETF, is trading at $77.83 with a 0.89% daily gain amid a challenging bond market environment. The ETF has declined 11% year-to-date and 46% over five years as Treasury yields reach multi-decade highs. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights significant bond market volatility with Treasury yields hitting levels not seen since 2007.
The outlook for TLT remains heavily dependent on interest rate direction, with current high yields presenting both income opportunity and continued price risk. Key risks include persistent inflation pressures and Federal Reserve policy uncertainty. Investors should weigh the attractive yield against potential further bond price declines if rates continue rising.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →
